Alector (ALEC)

• Market cap: $170M
• 1 day: -2.55%
• 5 days: -7.27%
• 1 month: -29.17%
• 3 months: -31.39%
• 6 months: 2.68%
• Year to date: 0%
• 1 year: -5.56%
• 5 years: -92.78%
• 10 years: -91.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Employees: 103